Trulieve Cannabis Corp Stock Price, News & Analysis

Trulieve Cannabis Corp. (OTCQX: TCNNF) announced a conference call set for May 10, 2023, at 8:30 AM ET, following the release of its first-quarter financial results for 2023. The call will feature key executives including Kim Rivers (CEO), Alex D'Amico (CFO), and Steve White (President), who will discuss the company's financial performance and operational outcomes. Interested participants can join the call via a dedicated toll-free number and passcode, or through a live audio webcast. An archived version of the webcast will also be accessible post-event on Trulieve's investor relations page. Trulieve continues to strengthen its market presence as a leading cannabis company across various U.S. regions, focusing on growth through retail and distribution expansion.

Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF), a leading U.S. cannabis company, announced its participation in the Benzinga Cannabis Capital Conference on April 11-12, 2023. Chief Marketing Officer Gina Collins will join a panel discussion on April 11 at 10:10 AM. Trulieve operates in multiple states, including Arizona, Florida, and Pennsylvania, focusing on growth and customer experience through a hub strategy. The company's established market positions aim to increase access to high-quality cannabis products. For more details about their event participation, visit Trulieve's events page.

Trulieve Cannabis Corp. announced the grand opening of a new medical dispensary in Palatka, Florida, on March 8, 2023. The dispensary, located at 101 North Highway 17, will operate from 9 a.m. to 9 p.m., Monday to Saturday, and from 10 a.m. to 8 p.m. on Sundays. To celebrate the opening, registered patients will receive a 30% discount along with various giveaways and activities throughout the day. Trulieve continues to lead Florida's medical cannabis market, offering the largest selection of THC and CBD products, and providing home delivery and online orders. The company aims to enhance patient access and customer experience.

Trulieve Cannabis Corp. (TCNNF) reported record revenue of $1.24 billion in 2022, a 32% increase year-over-year. Q4 revenue was $302 million, with a 2% sequential retail growth. The company operates 181 dispensaries across 11 states, expanding its footprint by 14%. Fourth quarter results included a GAAP gross margin of 50% and an adjusted EBITDA of $85 million. Despite these successes, Trulieve faced a net loss of $77 million and an adjusted net loss of $35 million. The company aims for cash generation while pursuing growth opportunities within the U.S. cannabis market.

Trulieve Cannabis Corp. announced the grand opening of its new medical cannabis dispensary in Beckley, West Virginia, on March 3, 2023. Located at 1000 N Eisenhower Dr., the dispensary operates from 10 a.m. to 8 p.m. on weekdays and 10 a.m. to 6 p.m. on Sundays. The opening festivities included giveaways, food, and a 25% discount for registered patients. Trulieve plans to offer a wide selection of THC products, including flower, concentrates, and tinctures. This new location enhances Trulieve's footprint in West Virginia, where it already operates additional dispensaries in cities like Huntington and Charleston.

On February 27, 2023, Trulieve Cannabis Corp. hosted a fireside chat in Atlanta with Civil Rights Leader Ambassador Andrew Young, celebrating Black History Month. The event, titled "The Work Continues," featured Young sharing insights from his experiences with Dr. Martin Luther King Jr., encouraging community leadership and activism. Trulieve's CEO, Kim Rivers, emphasized the company's commitment to Diversity, Equity, and Inclusion (DEI) programs, including its Supplier Diversity Program aimed at supporting diverse businesses. This event highlights Trulieve's ongoing dedication to community investment and social impact.

Trulieve Cannabis Corp. (OTCQX: TCNNF) announced a rescheduling of its fourth quarter and full year 2022 financial results and earnings call due to the transition to a large accelerated filer as of December 31, 2022. This change imposes a 60-day deadline for filing the Form 10-K, requiring additional time for audit completion. Consequently, Trulieve will file a Form 12b-25 and expects to submit its Form 10-K within a 15-day extension from the original March 1, 2023, due date. The earnings call is now set for March 8, 2023, featuring key executives discussing the financial and operational results.

Trulieve Cannabis Corp. is set to launch adult-use cannabis sales at its newly relocated dispensary in Bristol, Connecticut, on February 17, 2023, at 10 a.m. This event will feature a ribbon-cutting ceremony with food, music, and giveaways. The hybrid dispensary will operate Monday through Saturday from 9 a.m. to 8 p.m., and on Sundays from 10 a.m. to 6 p.m., reserving the first hour of each day for medical sales only. Trulieve has a longstanding presence in Connecticut, having served the medical market since 2014, and aims to enhance customer experience with a spacious showroom and ample parking. The company is positioned for growth in the adult-use market.

On February 15, 2023, Trulieve Cannabis Corp. (CSE: TRUL; OTCQX: TCNNF) became the first multi-state operator in the cannabis industry to launch advertising campaigns on Twitter, following a significant policy change by the platform allowing such advertisements. Trulieve's Chief Marketing Officer, Gina Collins, expressed excitement about this historic step towards normalizing cannabis use in the U.S. The company plans to expand its advertising efforts in compliance with state regulations across various markets. CEO Kim Rivers also acknowledged the opportunity for increased awareness of cannabis benefits through this partnership.